Acute Myeloid Leukemia Treatment Study
To provide cytarabine:daunorubicin liposome injection treatment for patients 60-75 years of age with newly diagnosed secondary AML and to collect additional data on treatment safety.
In order to participate you must meet the following criteria:
- Are age 60-75 years.
- Have a new diagnosis of AML.
You will be excluded from the study if any of the following criteria apply to you:
- Have a diagnosis of APL.
- Have had any major surgery within the last 4 weeks.
- Have kidney or liver diseases.
- Have any copper-metabolism disorder.
- Have heart failure.
This is a partial list of inclusion and exclusion criteria.